About Us

Company Summary

MobioSense focuses on fast-diagnosis platform and reagent development since founded in 2015, and successfully developed testing of COIVD-19 and African swine fever(ASFV) by using Isothermal nucleic acid amplification assay.

Our COVID-19 nucleic acid testing reagent have already certified by Taiwan FDA, is the first and only company in Taiwan which develop Isothermal nucleic acid amplification assay under in-vitro diagnostic (IVD) regulation.

Total solution provider

With the experience of manufacturing COVID-19 and ASFV testing, MobioSense now can tailor solution for customer from reagent to device. Besides COVID-19, MobioSense is collaborating with different hospitals and clinical labs, trying to develop different test items and build recognition of expert in fast-diagnostic field.